Reported a net loss of $3.63 million for Q1 2026, compared to a $2.70 million loss in Q1 2025. Generated $0 in revenue for the quarter, down from $12,003 in the prior year period. Operating expenses rose to $3.69 million, driven by increased R&D and G&A costs. Cash and cash equivalents stood at $16.41 million as of March 31, 2026. Successfully completed a February 2026 offering with net proceeds of $12.6 million. Announced a subsequent May 2026 offering expected to raise $27.7 million in net proceeds.